UA107473C2 - Конденсовані тіазоло- та оксазолопіримідинони - Google Patents
Конденсовані тіазоло- та оксазолопіримідинониInfo
- Publication number
- UA107473C2 UA107473C2 UAA201205825A UAA201205825A UA107473C2 UA 107473 C2 UA107473 C2 UA 107473C2 UA A201205825 A UAA201205825 A UA A201205825A UA A201205825 A UAA201205825 A UA A201205825A UA 107473 C2 UA107473 C2 UA 107473C2
- Authority
- UA
- Ukraine
- Prior art keywords
- oxazolopyrimidinons
- thiazolo
- condensed
- compounds
- pharmaceutically acceptable
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 4
- 239000003814 drug Substances 0.000 abstract 2
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/06—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
- C07D513/16—Peri-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Даний винахід також включає фармацевтично прийнятні композиції зазначених сполук і спосіб приготування нових сполук.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1249KO2009 | 2009-10-13 | ||
| PCT/IN2010/000579 WO2011045811A1 (en) | 2009-10-13 | 2010-08-31 | Fused thiazolo and oxazolo pyrimidinones |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA107473C2 true UA107473C2 (uk) | 2015-01-12 |
Family
ID=43034589
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA201205825A UA107473C2 (uk) | 2009-10-13 | 2010-08-31 | Конденсовані тіазоло- та оксазолопіримідинони |
Country Status (29)
| Country | Link |
|---|---|
| EP (1) | EP2385948B1 (uk) |
| JP (1) | JP5681195B2 (uk) |
| KR (1) | KR101710430B1 (uk) |
| CN (1) | CN102549000B (uk) |
| AR (1) | AR080616A1 (uk) |
| AU (1) | AU2010307984B2 (uk) |
| BR (1) | BR112012006233B8 (uk) |
| CA (1) | CA2772995C (uk) |
| CY (1) | CY1119710T1 (uk) |
| DK (1) | DK2385948T3 (uk) |
| EA (1) | EA020228B1 (uk) |
| ES (1) | ES2653931T3 (uk) |
| HR (1) | HRP20171976T1 (uk) |
| HU (1) | HUE038051T2 (uk) |
| IL (1) | IL219116A (uk) |
| LT (1) | LT2385948T (uk) |
| MX (1) | MX2012004074A (uk) |
| MY (1) | MY157629A (uk) |
| NO (1) | NO2385948T3 (uk) |
| NZ (1) | NZ598020A (uk) |
| PH (1) | PH12012500704A1 (uk) |
| PL (1) | PL2385948T3 (uk) |
| RS (1) | RS56630B1 (uk) |
| SI (1) | SI2385948T1 (uk) |
| SM (1) | SMT201700584T1 (uk) |
| TW (1) | TWI500623B (uk) |
| UA (1) | UA107473C2 (uk) |
| WO (1) | WO2011045811A1 (uk) |
| ZA (1) | ZA201203262B (uk) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI661828B (zh) * | 2013-05-14 | 2019-06-11 | 印度商托仁特生技有限公司 | 低劑量藥物組合物及其用途 |
| WO2016034108A1 (zh) | 2014-09-02 | 2016-03-10 | 广东东阳光药业有限公司 | 喹啉酮类化合物及其应用 |
| CN106905348B (zh) * | 2017-02-13 | 2018-12-04 | 牡丹江医学院 | 一种预防和治疗急性肾损伤的药物及其制备方法和用途 |
| CN110511233B (zh) * | 2019-08-08 | 2022-01-25 | 成都大学 | 一种噻唑并[2,3-b]噁唑酮类化合物及其制备方法和用途 |
| CN112778333B (zh) * | 2021-01-23 | 2022-07-05 | 中国科学院新疆理化技术研究所 | 一种四氢噁唑并吡啶并氮氧杂酮类衍生物及其用途 |
| AU2024259614A1 (en) * | 2023-04-18 | 2025-10-02 | Vanderbilt University | Thiazolopyridine derivatives as positive allosteric modulators of the muscarinic acetylcholine receptor m4 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4072679A (en) * | 1976-06-15 | 1978-02-07 | E. R. Squibb & Sons, Inc. | 1,4- AND 4,10-DIHYDRO-4-OXO-PYRIMIDO (1,2-A)-benzimidazole-3-carboxylic acids, esters and amides |
| US4423048A (en) | 1979-11-23 | 1983-12-27 | Pfizer Inc. | Antiallergic and antiulcer 1-oxo-1H-thiazolo[3,2-a]pyrimidine-2-carboxamides and intermediates therefor |
| DK151811C (da) * | 1979-11-23 | 1988-06-06 | Pfizer | Analogifremgangsmaade til fremstilling af n-(5-tetrazolyl)-1-oxo-1h-thiazolooe3,2-aaa-pyrimidin-2-carboxamider eller farmaceutisk acceptable kationsalte deraf samt 1-oxo-1h-thiazolooe3,2-aaapyrimidin-2-carboxylsyrer til anvendelse som udgangsmaterialer ved fremgangsmaaden |
| JPH0539293A (ja) * | 1991-01-23 | 1993-02-19 | Kyowa Hakko Kogyo Co Ltd | 免疫調節剤及びチアゾロピリミジン誘導体 |
| CA2138929A1 (en) | 1993-12-30 | 1995-07-01 | Klaus Weidmann | Substituted heterocyclic carboxamides, their preparation and their use as pharmaceuticals |
| JP2005524612A (ja) | 2001-12-06 | 2005-08-18 | ファイブローゲン、インコーポレーテッド | 内因性エリスロポエチン（ｅｐｏ）を増加させる方法 |
| RU2333203C2 (ru) | 2002-12-25 | 2008-09-10 | Дайити Фармасьютикал Ко., Лтд. | Диаминовые производные |
| US8614204B2 (en) | 2003-06-06 | 2013-12-24 | Fibrogen, Inc. | Enhanced erythropoiesis and iron metabolism |
| AU2007234408B2 (en) * | 2006-04-04 | 2011-05-19 | Fibrogen, Inc. | Pyrrolo- and thiazolo-pyridine compounds as HIF modulators |
| US7713986B2 (en) | 2006-06-15 | 2010-05-11 | Fibrogen, Inc. | Compounds and methods for treatment of chemotherapy-induced anemia |
| US20070293575A1 (en) | 2006-06-15 | 2007-12-20 | Fibrogen, Inc. | Compounds and methods for treatment of cancer-related anemia |
| AR061570A1 (es) * | 2006-06-23 | 2008-09-03 | Smithkline Beecham Corp | Compuesto de glicina sustituido en el n heteroaromatico composicion farmaceutica que lo comprende, su uso para preparar un medicamento, procedimientos para preparar dicha composicion farmaceutica y para preparar el compuesto |
| WO2009039322A1 (en) * | 2007-09-19 | 2009-03-26 | Smithkline Beecham Corporation | Prolyl hydroxylase inhibitors |
| WO2009039321A1 (en) * | 2007-09-19 | 2009-03-26 | Smithkline Beecham Corporation | Prolyl hydroxylase inhibitors |
-
2010
- 2010-08-30 TW TW099129121A patent/TWI500623B/zh not_active IP Right Cessation
- 2010-08-31 UA UAA201205825A patent/UA107473C2/uk unknown
- 2010-08-31 SI SI201031610T patent/SI2385948T1/en unknown
- 2010-08-31 ES ES10760108.0T patent/ES2653931T3/es active Active
- 2010-08-31 EP EP10760108.0A patent/EP2385948B1/en active Active
- 2010-08-31 AU AU2010307984A patent/AU2010307984B2/en not_active Ceased
- 2010-08-31 MY MYPI2012001679A patent/MY157629A/en unknown
- 2010-08-31 HR HRP20171976TT patent/HRP20171976T1/hr unknown
- 2010-08-31 WO PCT/IN2010/000579 patent/WO2011045811A1/en not_active Ceased
- 2010-08-31 NZ NZ598020A patent/NZ598020A/xx not_active IP Right Cessation
- 2010-08-31 DK DK10760108.0T patent/DK2385948T3/en active
- 2010-08-31 MX MX2012004074A patent/MX2012004074A/es active IP Right Grant
- 2010-08-31 KR KR1020127011052A patent/KR101710430B1/ko not_active Expired - Fee Related
- 2010-08-31 CA CA2772995A patent/CA2772995C/en active Active
- 2010-08-31 BR BR112012006233A patent/BR112012006233B8/pt not_active IP Right Cessation
- 2010-08-31 EA EA201270556A patent/EA020228B1/ru not_active IP Right Cessation
- 2010-08-31 NO NO10760108A patent/NO2385948T3/no unknown
- 2010-08-31 PH PH1/2012/500704A patent/PH12012500704A1/en unknown
- 2010-08-31 JP JP2012533740A patent/JP5681195B2/ja not_active Expired - Fee Related
- 2010-08-31 SM SM20170584T patent/SMT201700584T1/it unknown
- 2010-08-31 HU HUE10760108A patent/HUE038051T2/hu unknown
- 2010-08-31 RS RS20171226A patent/RS56630B1/sr unknown
- 2010-08-31 PL PL10760108T patent/PL2385948T3/pl unknown
- 2010-08-31 CN CN201080038159.2A patent/CN102549000B/zh not_active Expired - Fee Related
- 2010-08-31 LT LTEP10760108.0T patent/LT2385948T/lt unknown
- 2010-10-12 AR ARP100103718A patent/AR080616A1/es active IP Right Grant
-
2012
- 2012-04-05 IL IL219116A patent/IL219116A/en active IP Right Grant
- 2012-05-04 ZA ZA2012/03262A patent/ZA201203262B/en unknown
-
2017
- 2017-12-28 CY CY20171101352T patent/CY1119710T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201490807A1 (ru) | Новые замещенные имидазопиримидины как модуляторы рецептора gpbar1 | |
| MX2012002997A (es) | Derivados de eter de los heteroarilos biciclicos. | |
| PH12012500622A1 (en) | Compounds for the treatment of dyslipidemia and related diseases | |
| MX353209B (es) | Antagonistas d2, metodos de sintesis y metodos de uso. | |
| MY175854A (en) | Novel quinolone derivatives | |
| PH12013501557A1 (en) | Glucagon receptor modulator | |
| MX351305B (es) | Antagonistas del receptor de mineralocorticoides. | |
| TN2012000534A1 (en) | Pyrazole compounds as sigma receptor inhibitors | |
| IN2012DN03182A (uk) | ||
| PH12013500301A1 (en) | Oxadiazole inhibitors of leukotriene production | |
| WO2012135615A3 (en) | Enopeptins, uses thereof, and methods of synthesis thereto | |
| MX2014006433A (es) | Nuevos 2h-indazoles como antagonistas del receptor ep2. | |
| CY1119710T1 (el) | Συντηγμενες θειαζολο- και οξαζολο-πυριμιδινονες | |
| PH12016501903B1 (en) | Novel fused imidazobenzothiazole compounds | |
| PH12017501830A1 (en) | Novel pyridinium compounds | |
| PH12014501943A1 (en) | Novel compounds for the treatment of dyslipidemia and related diseases | |
| MX2013006768A (es) | Moduladores de receptor de glucagon. | |
| EA201290610A1 (ru) | Сульфоновые соединения в качестве лигандов 5-htрецептора | |
| PH12013500671A1 (en) | Novel gpr 119 agonists | |
| MX2012007253A (es) | Derivados triciclicos y sus usos y composiciones farmaceuticas. | |
| PH12017500323B1 (en) | P38 map kinase inhibiting indanyl urea compounds | |
| GEP20156269B (en) | New secondary 8-hydroxyquinoline-7- carboxamide derivatives | |
| MX2014000855A (es) | Moduladores receptores de glucagon de quinolinilo. | |
| MX2010011767A (es) | Derivados de benzocicloheptano y benzoxepina. | |
| WO2011128699A3 (en) | Novel process for the preparation of sunitinib |